Weiss, J.M. et al., "An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function," J. Cell. Biol. 137:1137-1147 (Jun. 1997). |
Tolg, C. et al., "Splicing Choice from Ten Variant Exons Establishes CD44 Variability," Nucl. Acids Res. 21:1225-1229 (1993). |
Claas, C. et al., "Developmentally Regulated Expression of Metastasis-Associated Antigens in the Rat," Cell Growth Differat. 7: 663-678 (1996). |
Sandmaier et al. Blood 91: 3494-3502 (1998). |
Brennan Clin. Exp. Immunol. 97: 1-3 (1994). |
Wittig et al. Immunology Letters 57: 217-223 (1997). |
I. Albeldo Faseb J. 8: 504-512 (1994). |
Cobbold et al., Nature 312?: 548-551 (1984). |
Galuzzo et al. Eur. J. Immunol. 25: 2932-2939 Given at interview (#28) (1995). |
Ward et al. Therapeutic Immunology 1: 165-171 (1994). |
Zoller et al. Onkologie 17: 114-122 (1994). |
Mountain et al. Biotech & Gen. Eng. Rev. 10: pp. 10-11 (1993). |
Edgington et al. Biotechnology 10: 383-389 (1992). |
Shaffer Biotechnology News Watch p. 9 Oct. 4, 1993. |
Borre Breck et al. Immunol. Today 14: 477-479 (1993). |
Joliffe Intern Rev. Immunol. 10: 241-50 (1993). |
Koopman et al. J Exp Med 177: 897-904 (1993). |
Harris et al. Tibtech 11: 42-44 (1993). |
Waldmann Science 252: 1657-1662 (1991). |
Vitetta et al. Ann. Rev. Immunol. 9: 193-217 (1991). |
Hofmann et al. Cancer Res. 51: 5292-5297 (1991). |
Stamenkovic et al. Embo J. 10: 343-348 (1991). |
Neu, S., et al., "Expression Of CD44 Isoforms By Highly Enriched CD34-Positive Cells In Cord Blood, Bone Marrow And Leukaphereses," Bone Marrow Transplantation, 20:593-598 (1997). |
Griffioen, A.W, et al., "Expression of CD44 Splice Variants During Lymphocyte Activation and Tumor Progression," Cell Adhesion and Communication, 2:195-200, (1994). |
Levesque, M.C., et al., "In Vitro Culture Of Human Peripheral Blood Monocytes Induces Hyaluronan Binding And Up-Regulates Monocyte Variant CD44 Isoform Expression," J. Immunol. 156:1157-1565, (1996). |
Pals, S.T., et al., "CD44 Splice Variants: Expression During Lymphocyte Activation and Tumor Progression," Behring Inst. Mitt., 92:273-277 (1993). |
Camp, R.L. et al., "High levels of CD44 expression distinguish virgin from antigen-primed B cells", J. Exp. Med. 173:763-766 (Mar. 1991). |
Gunthert, U. et al., "A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells", Cell 65:13-24 (Apr. 5, 1991). |
Huet, S. et al., "CD44 contributes to T cell activation", J. Immunol. 143(3):798-801 (Aug. 1, 1989). |
Jalkanen, S. et al., "Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells", J. Cell Biol. 105:983-990 (Aug. 1987). |
Jalkanen, S.T. et al., "A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man", Eur. J. Immunol. 16:1195-1202 (1986). |
Jerne, N.K. & Nordin, A.A., "Plaque formation in agar by singele antibody-producing cells", Science 140:405 (Apr. 26, 1963). |
Matzku, S. et al., "Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies", Cancer Research 49:1294-1299 (Mar. 1, 1989). |
Reber, S. et al., "Retardation of metastatic tumor growth after immunization with metastatsis-specific monoclonal antibodies", Int. J. Cancer 46:919-927 (1990). |
Shimizu, Y. et al., "Dual role of the CD44 molecule in T cell adhesion and activation", J. Immunol. 143(8):2457-2463 (Oct. 15, 1989). |
Stamenkovic, I. et al., "A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family", Cell 56:1057-1062 (Mar. 24, 1989). |
Zoller, M. & Andrighetto, G., "Comparison between the in Vitro activities of in Vivo-induced hapten-specific suppressor cells and supernatants of a hapten-specific suppressor hybridoma", Cellul. Immunol. 89:310-321 (1984). |
Kavanaugh et al., Treatment of Refractory Rheumatoid Arthritis with Anti-CD54 Intercellular Adhesion Molecule-1 (ICAM-1) Monoclonal Antibody, Arthritis and Rheumatism, vol. 35.9, S43:53 (Sep. 1992). |